Extract

RATIONALE: Diagnostic imaging procedures, such as radiolabeled monoclonal antibodies, may improve the ability to detect the residual disease in patients who have been treated for non-Hodgkin's lymphoma. PURPOSE: Phase II/III trial to study the effectiveness of monoclonal antibodies in detecting residual disease in patients who have been treated for non-Hodgkin's lymphoma.

Inclusion criteria

• LYMPHOMA

Country

• Austria
• Italy
• Sweden
• Switzerland
• United States

Links

• ictrp
• nct